POINT Biopharma

[Available On-Demand]
POINT Biopharma is a clinical-stage global pharmaceutical company focused on the development and commercialization of radioligand therapies for the treatment of cancer.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Ontario
Company HQ Country:
Canada
Year Founded:
2019
Main Therapeutic Focus:
Oncology
Lead Product in Development:
PNT 2003
Development Phase of Primary Product:
Phase III
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
CEO
POINT Biopharma